1
60
C. Iturbe et al. / Polyhedron 118 (2016) 159–170
Avance of 400 MHz, 1H NMR spectra were recorded at 400 MHz
C-Br) cm . 1H NMR (400 MHz, CDCl
ꢀ1
, ppm) d 8.36 (d, J = 5.1 Hz,
3
using CDCl
3
1
as the solvent and TMS as internal standard
1H), 7.85 (s, 1H), 7.65 (d, J = 5.0 Hz, 1H), 3.82 (s, 3H).
3
(
0.00 ppm). C NMR spectra were recorded in CDCl
3
at 101 MHz.
The electrochemical characterization of the Iridium complex was
performed by means of cyclic voltammetry (CV) in ACN as a sol-
vent, using a three-electrode cell consisting of a platinum working
electrode, a platinum wire auxiliary electrode and standard
Ag/AgCl electrode as the reference electrode with a scan rate of
3.1.1.3. Methyl 2-(m-tolyl)isonicotinate (L1). In a micro reactor ves-
sel, bromopyridne (3) (3.1 eq), 30 mL of DME, and Pd(Ph )
3 4
(0.015 eq) were added. The mixture was stirred for 10 min under
inert atmosphere. When the time was over, boronic acid (4,
1.2 eq) and K
at its boiling point for 2 days. Finally the reaction was filtered
under vacuum and the filtrate was extracted with CHCl . The crude
2 3
CO (2.4 eq) were added. The mixture was heated
ꢀ1
ꢀ1
ꢀ1
1
00 mV * s
.
The solutions were 1 ꢁ 10 mol/L
in the
corresponding complex, and contained tetrabutylamonium hex-
3
ꢀ1
ꢀ1
afluorophosphate 1 ꢁ 10 mol/L as supporting electrolyte. The
emission spectra were recorder on a PerkinElmer LS 55 Fluores-
cence spectrometer with slit of 2.5 cm. The absorption spectra
were recorder on a Shimadzu UV-3101PC UV–VIS-NIR Spectropho-
tometer. The X-rays diffraction were obtained on a STOE IPDS II
two-circle. The structure was solved by direct methods using
product was purified by silica gel chromatography using petroleum
benzine/ethyl acetate (1:1) as mobile phase. The contents of the
organic phase were removed in vacuo to obtain an orange oil cor-
responding to methyl 2-(m-tolyl)isonicotinate, L1, with 80% yield.
1
3
H NMR (400 MHz, CDCl , ppm) d, 8.81 (d, J = 5.0 Hz, 1H), 8.28
(s, 1H), 7.88 (s, 1H), 7.82 (d, J = 7.8 Hz, 1H), 7.75 (dd, J = 5.0,
1
3
1
1
.3 Hz, 1H), 7.37 (t, J = 7.7 Hz, 1H), 7.27 – 7.23 (m, 1H), 3.97 (s,
SHELXS; and Figures were created using the PLATON software.
Finally, for the quantum yields for all complexes, using [Ru
1
3
H), 2.44 (s, 3H).
3
C NMR (101 MHz, CDCl , ppm) 165.79,
58.62, 150.31, 138.57, 138.37, 138.14, 130.36, 128.79, 127.78,
27.64, 124.19, 121.05, 119.96, 119.77, 77.16, 52.75, 21.52.
(
3 6
bpy) ](PF )2, as reference compound was calculated using stan-
dard reported methods [9].
3.1.1.4. Methyl 2-phenylisonicotinate (L2). This ligand was obtained
3
. Computational details
with 86% yield using a similar procedure than the one described for
L1.
1H NMR (400 MHz, CDCl3, ppm) d, 8.75 (d, J = 4.8 Hz, 1H), 8.21
(s, 1H), 7.97 (d, J = 7.2 Hz, 2H), 7.68 (d, J = 4.8 Hz, 1H), 7.39 (dt,
All calculations were performed on ADF framework [10] and the
geometries were optimized with the OPBE [11] exchange correla-
tion functional, including the scalar relativistic correction [12] in
conjunction with ZORA-TZP and DZP basis set for Iridium and
atoms from the first row. Hirschfeld fragment analysis [13] was
employed to study the composition of the molecular orbitals in
sets of four fragments, including the metal core(M), the ancillary
acac ligand(L), and the phenylpyridine ligand, which in turn is
decomposed in the two fragments: phenyl(F) and piridyne(P).
The TDDFT calculations were performed in presence of acetonitrile
as solvent and employing a Klamt surface [14]. The first 40 allowed
and not allowed excitations were calculated with ZORA-SZ basis
set for C,H,N,O and the SOAP exchange correlation potential [15].
1
3
J = 21.7, 7.0 Hz, 3H), 3.90 (s, 3H). C NMR (101 MHz, CDCl3,
ppm), 165.88, 158.57, 150.55, 138.61, 138.2, 129.58, 128.97,
127.10, 121.23, 119.81, 52.83.
3.1.1.5. Methyl 2-(m-tolyl)pyridine (L3). This ligand was obtained
with 86% yield using a similar procedure than the one described
for L1.
1
H NMR (400 MHz, CDCl , ppm) d 8.53 (d, J = 4.9 Hz, 1H), 7.97
3
(d, J = 7.2 Hz, 2H), 7.52 (s, 1H), 7.45 (t, J = 7.3 Hz, 2H), 7.39
(d, J = 7.2 Hz, 1H), 7.02 (d, J = 4.4 Hz, 1H), 2.38 (s, 3H). 13C NMR
(101 MHz, CDCl , ppm) d 157.45, 149.50, 147.79, 139.62, 128.81,
3
1
28.70, 127.01, 123.20, 121.60, 21.28.
3.1. Procedure for ligand synthesis
2
3.2. General procedure to obtain [Ir(C^N)2(l-Cl)] dimers [17]
3
3
.1.1. Preparation of methyl 2-(m-tolyl)isonicotinate (L1) [16]
.1.1.1. 2-Bromoisonicotinic acid (2). A mixture of 2-bromo-4-
All dimers were synthetized by the following procedure:
To a 100 mL round bottom flask 1 eq of IrCl in methylethylene
3
methylpiridine, 1, (9.27 g, 54 mmol) in 490 mL of water, and of
KMnO (16 g, 11 mmol) in 250 mL of water were stirred for 5 h
at 110 °C. The resulting mixture was filtered and the filtrate was
reduced to 1/3 and acidified with HCl until pH 3. The white precip-
itated obtained was filtered and dried, Yield: 36% of 2-bromoison-
icotinic acid.
glycol (5 mL for each 150 mg) were added. The flask was attached
to a condenser and the system set under nitrogen atmosphere, and
then the corresponding L(i) ligand (2.5 eq) was added. The reaction
was carried out at reflux in a silicone bath for a period of 12 h.
Then, the heating was stopped and the reaction allowed to cool.
The contents of the flask were removed in vacuo to afford the crude
compound was purified with a minimal amount of hexane/ethyl
acetate (1:1) and stirred a few seconds. Finally, a few drops of hex-
ane were added to precipitate the complex that was separated
from the solution by filtering, yield 98%.
4
FT-IR (KBr)
m, 3100–2350 (stretching O–H), 1710 (str. C@O),
1
cm
0
597 (str. C@C), 1546 (str. C@N), 1285 (str. C–O), 667 (str. C-Br)
ꢀ
1
1
.
6
H NMR (400 MHz, DMSO-d , ppm) d, 8.58 (dd, J = 5.0,
.8 Hz), 7.95 (dd, J = 1.4, 0.8 Hz), 7.84 (dd, J = 5.0, 1.4 Hz).
3
.1.1.2. Methyl 2-bromoisonicotinate (3). A mixture of 2-bromoison-
3.2.1. Bis[
l
-chloro di-(2-m-tolylisonicotinate)iridium III] (5),
H NMR (400 MHz, CDCl , ppm) d 9.31 (d, J = 6.0 Hz, 3H), 8.42 (s,
3H), 7.44 (s, 3H), 7.39–7.08 (m, 5H), 6.45 (d, J = 7.5 Hz, 3H), 5.77 (d,
1
icotinic acid, 2, (0.200 g, 0.99 mmol) in acetone and K
1
time was over CH
ture refluxed for 2 h. Finally the mixture was cooled and left over
ice, and the product extracted with CHCl . The organic phase was
dried with Na SO , and purified by silica gel chromatography with
CHCl as mobile phase. The contents of the organic phase were
removed in vacuo to obtain methyl 2-bromoisonicotinate with
3
PO
4
(0.290 g,
3
.09 mmol) was stirred for 30 min at room temperature. When the
1
3
3
I (0,155 g, 1.09 mmol) was added and the mix-
J = 7.9 Hz, 3H), 4.12 (s, 9H), 2.15 (s, 10H). C NMR (101 MHz,
CDCl , ppm) d 169.30, 164.80, 151.54, 142.26, 140.85, 137.12,
130.87 (d), 129.99, 125.00, 120.80, 117.69, 52.89, 20.65.
3
3
2
4
3
3.2.2. Bis[l-chloro di(2-phenylisonicotinate)iridium III] (6)
1
Yield 99%. H NMR (400 MHz, CDCl
3
, ppm) d 9.32 (s, 1H), 8.45 (s,
8
2% yield.
FT-IR (KBr)
1H), 7.63 (d, J = 7.6 Hz, 1H), 7.20 (d, J = 5.5 Hz, 1H), 6.81 (t,
J = 7.3 Hz, 1H), 6.61 (t, J = 7.4 Hz, 1H), 5.90 (d, J = 7.7 Hz, 1H), 4.12
3
m = 3089 (str. C–H sp ), 2955 (str. C–H sp2), 1722
1
3
(
str. C@O), 1588 (str. C@C aromatic), 1546 (str. C@N), 670 (str.
(s, 3H).
3
C NMR (101 MHz, CDCl , ppm) d 169.64, 164.96,